{"meshTagsMajor":["Gastrointestinal Neoplasms","Gastrointestinal Stromal Tumors","Precision Medicine"],"meshTags":["Evidence-Based Medicine","Gastrointestinal Neoplasms","Gastrointestinal Stromal Tumors","Humans","Mutation","Precision Medicine","Prognosis"],"meshMinor":["Evidence-Based Medicine","Humans","Mutation","Prognosis"],"publicationTypes":["Editorial","English Abstract"],"abstract":"With the development of tumor molecular diagnosis and the administration of targeted drugs, cancer treatment has gradually entered a new era of precision medicine. The diagnosis and treatment of gastrointestinal stromal tumor (GIST) is a full embodiment of the concept of precision medicine, but there are still many problems needed to be solved in the clinical diagnosis and treatment of GIST (such as the correlation between the gene mutation and prognosis, the treatment strategy of wild type GIST and the drug resistance phenomenon).","title":"[New challenges in the diagnosis and treatment of gastrointestinal stromal tumor: thinking and practice from evidence-based medicine to precision medicine].","pubmedId":"26797831"}